Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Drug Discovery Today. Technologies|September 21, 2013
Dualsteric GPCR targeting and functional selectivity: the paradigmatic M(2) muscarinic acetylcholine receptorAndreas Bock, Klaus Mohr
International Journal of Environmental Research and Public Health|June 10, 2022
Effects of COVID-19 Restriction Policies on Urban Heat Islands in Some European Cities: Berlin, London, Paris, Madrid, and FrankfurtTaher Safarrad, Mostafa Ghadami, Andreas Dittmann
Pharmazie in Unserer Zeit|October 25, 2007
[Angiogenesis inhibitors for vision loss. Ranibizumab for macular degeneration]Marion Mohr-Andrä, Klaus Mohr
Neuropharmacology|September 23, 2017
Allosteric modulators targeting CNS muscarinic receptorsAndreas Bock, Ramona Schrage, Klaus Mohr
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 23, 2018
N-Ethylmaleimide differentiates between the M2- and M4-autoreceptor-mediated inhibition of acetylcholine release in the mouse brainJustine Etscheid, Klaus Mohr, Eberhard Schlicker
Pharmazie in Unserer Zeit|October 25, 2007
[Angiogenesis inhibitors in cancer therapy. Bevacizumab against colon carcinoma]Christian Fieth, Anna Kebig, Klaus Mohr
Journal of Molecular Neuroscience : MN|December 29, 2006
Allosteric modulators and selective agonists of muscarinic receptorsUlrike Holzgrabe, Marco De Amici, Klaus Mohr
Journal of Medicinal Chemistry|March 18, 2005
Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agentsMathias Muth, Matthias Sennwitz, Klaus Mohr, et al.
Pageof 6